FIELD: medicine, hematology. SUBSTANCE: method involves the use of cryoprecipitate or blood plasma as raw that can be treated subsequently if necessary with aluminium hydroxide. After cryoprecipitate dissolving at least a single stage of separation is carried out. Alternative aspect of invention is factor VIII-containing fraction that is subjected for inactivation with virus and additional pasteurization procedure preferably. EFFECT: broadened arsenal of agents used for therapy of coagulating blood system damages. 14 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
| METHOD OF PURIFYING GROWTH FACTOR PROTEIN | 2011 |
|
RU2571926C2 |
| METHOD OF PRODUCING FACTOR VIII, HAVING IMPROVED RATIO FVIII:C/FVIII:AG | 2015 |
|
RU2695428C2 |
| METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT | 2004 |
|
RU2370500C2 |
| METHOD OF PURIFYING COAGULATION FACTOR VIII | 2009 |
|
RU2698392C2 |
| METHOD FOR PURIFICATION OF BLOOD-COAGULATION FACTOR VIII | 2009 |
|
RU2567811C2 |
| METHOD OF PURIFYING VITAMIN K-DEPENDENT PROTEINS, SUCH AS COAGULATION FACTOR VII | 2011 |
|
RU2731720C2 |
| METHOD FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IX | 2011 |
|
RU2590726C2 |
| ALBUMIN SOLUTION AND METHOD FOR PRODUCTION THEREOF | 2004 |
|
RU2305556C2 |
| METHOD FOR ISOLATION OF HIGHLY PURIFIED COMPLEX OF VIII FACTOR FROM WILLEBRANDE FACTOR | 1993 |
|
RU2096414C1 |
